| Host: |
HEK293 cells |
| Reactivity: |
SARS-CoV-2 |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta)-C-His&Avi protein was developed from hek293 cells and has a target region of C-His&Avi. For use in research applications. |
| Formulation: |
Supplied as a 0.22 Mu m filtered solution in 20 mM TRIS, 150 mM NaCl, 10% Glycerol, pH8.0. |
| Immunogen: |
Recombinant SARS-CoV-2 Nucleocapsid (B.1.617.2/Delta) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2-Ala419 (D63G, R203M, D377Y) ) of sars-cov-2 N (B.1.617.2/Delta) (Accession #YP_009724397.2) fu |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
